Xiaoduo Fan, MD, MPH | Psychiatrist.com

Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder

Original Research

Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder

October 13, 2025

This pilot trial suggests that brexpiprazole might be beneficial in reducing substance craving and use and improve quality of life in this difficult-to-treat patient population.

Xiaoduo Fan, Oliver Freudenreich, L. Fredrik Jarskog, et al

Original Research

The Triglyceride/HDL Cholesterol Ratio

November 2, 2010

Read the full study on using the Triglyceride/HDL Cholesterol Ratio to predict Insulin Resistance and Low-Density Lipoprotein Cholesterol Particle Size.

David C. Henderson, Xiaoduo Fan, Vicki Poole Hoffman, et al

Original Research

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

August 11, 2009

A. Eden Evins, David C. Henderson, Oliver Freudenreich, et al

Original Research

Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics

April 16, 2007

David C. Henderson, Oliver Freudenreich, Donald C. Goff, et al